Securities SettlementsDavita Inc (NYSE:DVA) Shareholder Lawsuit Settlement

Did you purchase Davita Inc (NYSE:DVA) stock between 02/26/2015 and 10/06/2017? If so, you may be entitled to compensation, Call 1-800-934-2921 or complete the form on this page for a free consultation.
February 5, 2021

Our law firm is filing potential claims on behalf of shareholders of Davita Inc (NYSE:DVA), stemming from a recent settlement of a shareholder lawsuit against the company.

Did you purchase Davita Inc (NYSE:DVA) stock between 02/26/2015 and 10/06/2017? If so, you may be entitled to compensation,
Call 1-800-934-2921 or complete the form on this page for a free consultation.

Our law firm is filing claims on behalf of Davita Inc (NYSE:DVA) shareholders stemming from the recent $135 million settlement of the shareholder lawsuit against the company. If you purchased Davita Inc (NYSE:DVA) during the class period above, contact our law firm to protect your rights.

DaVita, Inc. Agrees to Multimillion Dollar Settlement

DaVita, Inc. is a large Denver based kidney disease service provider. The company offers services for patients in active kidney failure or those who are suffering from what is known as end stage renal disease. In a move that surprised many industry observers but pleased many stockholders, company officials have agreed to a massive financial settlement. They will pay a hundred and thirty-five million dollars to their shareholders. The settlement comes after many years of intense litigation efforts. For more than three years, company officials have battled allegations of wrongdoing. Multiple allegations have put company operations in long-term jeopardy.

Initial Complaint

In 2017, serious allegations were filed against officials at the company. Company officials are alleged to have made many false statements. The allegations also alleged that senior officials at the company deliberately arranged to push patients into insurance plans they didn’t need in order to increase profits. They also argue that officials at the company went against the policies and procedures designed by the American Kidney Fund to help patients again in order to increase the company’s bottom line. In addition, company officials are alleged to have failed to follow established financial procedures intended to offer oversight of the industry.

Illegal Profits

As a result of these efforts, company officials are alleged to have ultimately made millions in profits that were obtained illegally. They ultimately allege that this allowed the company to earn funds that should have been diverted to helping patients and following established procedures to avoid fraud. These allegations have gone for many years and involved multiple parties. Those who watch the company’s policies and stocks are not shocked that DaVita, Inc. has agreed to a settlement.

Settlement of Davita Inc (NYSE:DVA) Shareholder Lawsuit

Davita Inc (NYSE:DVA) investors may be able to collect significant financial compensation for their losses. The recent settlement with the company has set aside potentially $135 million dollars for compensating shareholders.

Buy shares of DVA? Davita Inc (NYSE:DVA) Shareholder Lawsuit Settlement. Contact us to protect your rights.

Did you purchase Davita Inc (NYSE:DVA) stock between 02/26/2015 – 10/06/2017? If so, you may be entitled to compensation,
Call 1-800-934-2921 or complete the form on this page for a free consultation.